Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 9/2023

08-08-2023 | Acute Kidney Injury | Review

Precision management of acute kidney injury in the intensive care unit: current state of the art

Authors: Natalja L. Stanski, Camila E. Rodrigues, Michael Strader, Patrick T. Murray, Zoltan H. Endre, Sean M. Bagshaw

Published in: Intensive Care Medicine | Issue 9/2023

Login to get access

Abstract

Acute kidney injury (AKI) is a prototypical example of a common syndrome in critical illness defined by consensus. The consensus definition for AKI, traditionally defined using only serum creatinine and urine output, was needed to standardize the description for epidemiology and to harmonize eligibility for clinical trials. However, AKI is not a simple disease, but rather a complex and multi-factorial syndrome characterized by a wide spectrum of pathobiology. AKI is now recognized to be comprised of numerous sub-phenotypes that can be discriminated through shared features such as etiology, prognosis, or common pathobiological mechanisms of injury and damage. The characterization of sub-phenotypes can serve to enable prognostic enrichment (i.e., identify subsets of patients more likely to share an outcome of interest) and predictive enrichment (identify subsets of patients more likely to respond favorably to a given therapy). Existing and emerging biomarkers will aid in discriminating sub-phenotypes of AKI, facilitate expansion of diagnostic criteria, and be leveraged to realize personalized approaches to management, particularly for recognizing treatment-responsive mechanisms (i.e., endotypes) and targets for intervention (i.e., treatable traits). Specific biomarkers (e.g., serum renin; olfactomedin 4 (OLFM4); interleukin (IL)-9) may further enable identification of pathobiological mechanisms to serve as treatment targets. However, even non-specific biomarkers of kidney injury (e.g., neutrophil gelatinase-associated lipocalin, NGAL; [tissue inhibitor of metalloproteinases 2, TIMP2]·[insulin like growth factor binding protein 7, IGFBP7]; kidney injury molecule 1, KIM-1) can direct greater precision management for specific sub-phenotypes of AKI. This review will summarize these evolving concepts and recent innovations in precision medicine approaches to the syndrome of AKI in critical illness, along with providing examples of how they can be leveraged to guide patient care.
Literature
1.
Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, Kashani K, Koyner JL, Pannu N, Meersch M et al (2023) Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 19:401–417PubMedCrossRef
2.
Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L et al (2012) The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 38(10):1573–1582PubMedCrossRef
3.
Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533
4.
Disease K (2012) Improving Global Outcomes: KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int 2:1–138
5.
Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H et al (2019) Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA 321(20):2003–2017PubMedPubMedCentralCrossRef
6.
7.
Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, Baron RM, Bauer M, Buchman TG, Calfee CS et al (2022) Redefining critical illness. Nat Med 28(6):1141–1148PubMedCrossRef
8.
Reddy K, Sinha P, O’Kane CM, Gordon AC, Calfee CS, McAuley DF (2020) Subphenotypes in critical care: translation into clinical practice. Lancet Respir Med 8(6):631–643PubMedCrossRef
9.
Vaara ST, Bhatraju PK, Stanski NL, McMahon BA, Liu K, Joannidis M, Bagshaw SM (2022) Subphenotypes in acute kidney injury: a narrative review. Crit Care 26(1):251PubMedPubMedCentralCrossRef
10.
Krewulak KD, Stelfox HT, Ely EW, Fiest KM (2020) Risk factors and outcomes among delirium subtypes in adult ICUs: A systematic review. J Crit Care 56:257–264PubMedCrossRef
11.
Neyton LPA, Zheng X, Skouras C, Doeschl-Wilson A, Gutmann MU, Uings I, Rao FV, Nicolas A, Marshall C, Wilson LM et al (2022) Molecular Patterns in Acute Pancreatitis Reflect Generalizable Endotypes of the Host Response to Systemic Injury in Humans. Ann Surg 275(2):e453–e462PubMedCrossRef
12.
Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, Network NA (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2(8):611–620PubMedPubMedCentralCrossRef
13.
Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O’Kane CM, McAuley DF et al (2018) Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 6(9):691–698PubMedPubMedCentralCrossRef
14.
Rodrigues CE, Endre ZH (2023) Definitions, phenotypes, and subphenotypes in acute kidney injury-Moving towards precision medicine. Nephrology (Carlton) 28(2):83–96PubMedCrossRef
15.
de Caestecker M, Humphreys BD, Liu KD, Fissell WH, Cerda J, Nolin TD, Askenazi D, Mour G, Harrell FE Jr, Pullen N et al (2015) Bridging Translation by Improving Preclinical Study Design in AKI. J Am Soc Nephrol 26(12):2905–2916PubMedPubMedCentralCrossRef
16.
Liu KD, Humphreys BD, Endre ZH (2017) The ten barriers for translation of animal data on AKI to the clinical setting. Intensive Care Med 43(6):898–900PubMedPubMedCentralCrossRef
17.
Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, Bell M, Forni L, Guzzi L, Joannidis M et al (2020) Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw Open 3(10):e2019209PubMedCrossRef
18.
Juncos LA, Wieruszewski PM, Kashani K (2022) Pathophysiology of Acute Kidney Injury in Critical Illness: A Narrative Review. Compr Physiol 12(4):3767–3780PubMedCrossRef
19.
Pickkers P, Darmon M, Hoste E, Joannidis M, Legrand M, Ostermann M, Prowle JR, Schneider A, Schetz M (2021) Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med 47(8):835–850PubMedPubMedCentralCrossRef
20.
21.
Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281(5):F887-899PubMedCrossRef
22.
Funk JA, Schnellmann RG (2012) Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 302(7):F853-864PubMedCrossRef
23.
Jiang M, Wei Q, Dong G, Komatsu M, Su Y, Dong Z (2012) Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 82(12):1271–1283PubMedPubMedCentralCrossRef
24.
Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22(2):317–326PubMedPubMedCentralCrossRef
25.
Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16(5):535–543PubMedPubMedCentralCrossRef
26.
Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH (2010) Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 14(3):R85PubMedPubMedCentralCrossRef
27.
Khorashadi M, Beunders R, Pickkers P, Legrand M (2020) Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury. Nephron 144(12):655–661PubMedCrossRef
28.
Andrew BY, Pieper CF, Cherry AD, Pendergast JF, Privratsky JR, Mathew JP, Stafford-Smith M (2022) Identification of Trajectory-Based Acute Kidney Injury Phenotypes Among Cardiac Surgery Patients. Ann Thorac Surg 114(6):2235–2243PubMedCrossRef
29.
Bhatraju PK, Mukherjee P, Robinson-Cohen C, O’Keefe GE, Frank AJ, Christie JD, Meyer NJ, Liu KD, Matthay MA, Calfee CS et al (2016) Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death. Crit Care 20(1):372PubMedPubMedCentralCrossRef
30.
31.
Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, Bachler M, Hoste EAJ, Hoiting O, Krell K et al (2018) Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial. JAMA 320(19):1998–2009PubMedPubMedCentralCrossRef
32.
Xu K, Rosenstiel P, Paragas N, Hinze C, Gao X, Huai Shen T, Werth M, Forster C, Deng R, Bruck E et al (2017) Unique Transcriptional Programs Identify Subtypes of AKI. J Am Soc Nephrol 28(6):1729–1740PubMedCrossRef
33.
Endre ZH, Kellum JA, Di Somma S, Doi K, Goldstein SL, Koyner JL, Macedo E, Mehta RL, Murray PT (2013) Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 182:30–44PubMedCrossRef
34.
Gocze I, Jauch D, Gotz M, Kennedy P, Jung B, Zeman F, Gnewuch C, Graf BM, Gnann W, Banas B et al (2018) Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann Surg 267(6):1013–1020PubMedCrossRef
35.
Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 43(11):1551–1561PubMedPubMedCentralCrossRef
36.
Johnson ACM, Zager RA (2018) Mechanisms Underlying Increased TIMP2 and IGFBP7 Urinary Excretion in Experimental AKI. J Am Soc Nephrol 29(8):2157–2167PubMedPubMedCentralCrossRef
37.
38.
Delucchi K, Famous KR, Ware LB, Parsons PE, Thompson BT, Calfee CS, Network A (2018) Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax 73(5):439–445PubMedCrossRef
39.
Maddali MV, Churpek M, Pham T, Rezoagli E, Zhuo H, Zhao W, He J, Delucchi KL, Wang C, Wickersham N et al (2022) Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Lancet Respir Med 10(4):367–377PubMedPubMedCentralCrossRef
40.
Sanchez-Pinto LN, Stroup EK, Pendergrast T, Pinto N, Luo Y (2020) Derivation and Validation of Novel Phenotypes of Multiple Organ Dysfunction Syndrome in Critically Ill Children. JAMA Netw Open 3(8):e209271PubMedPubMedCentralCrossRef
41.
Chaudhary K, Vaid A, Duffy A, Paranjpe I, Jaladanki S, Paranjpe M, Johnson K, Gokhale A, Pattharanitima P, Chauhan K et al (2020) Utilization of Deep Learning for Subphenotype Identification in Sepsis-Associated Acute Kidney Injury. Clin J Am Soc Nephrol 15(11):1557–1565PubMedPubMedCentralCrossRef
42.
Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, Morrell ED, Robinson-Cohen C, Calfee CS, Christie JD et al (2019) Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy. Am J Respir Crit Care Med 199(7):863–872PubMedPubMedCentralCrossRef
43.
Wiersema R, Jukarainen S, Vaara ST, Poukkanen M, Lakkisto P, Wong H, Linder A, van der Horst ICC, Pettila V (2020) Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery. Crit Care 24(1):150PubMedPubMedCentralCrossRef
44.
Bhatraju PK, Cohen M, Nagao RJ, Morrell ED, Kosamo S, Chai XY, Nance R, Dmyterko V, Delaney J, Christie JD et al (2020) Genetic variation implicates plasma angiopoietin-2 in the development of acute kidney injury sub-phenotypes. BMC Nephrol 21(1):284PubMedPubMedCentralCrossRef
45.
Vasquez-Rios G, Oh W, Lee S, Bhatraju P, Mansour SG, Moledina DG, Gulamali FF, Siew ED, Garg AX, Sarder P et al (2023) Joint modeling of clinical and biomarker data in acute kidney injury defines unique subphenotypes with differing outcomes: The ASSESS-AKI Study. Clin J Am Soc Nephrol 18(6):716–726PubMedCrossRef
46.
Zador Z, Landry A, Cusimano MD, Geifman N (2019) Multimorbidity states associated with higher mortality rates in organ dysfunction and sepsis: a data-driven analysis in critical care. Crit Care 23(1):247PubMedPubMedCentralCrossRef
47.
Fiorentino M, Xu Z, Smith A, Singbartl K, Palevsky PM, Chawla LS, Huang DT, Yealy DM, Angus DC, Kellum JA et al (2020) Serial Measurement of Cell-Cycle Arrest Biomarkers [TIMP-2]. [IGFBP7] and Risk for Progression to Death, Dialysis, or Severe Acute Kidney Injury in Patients with Septic Shock. Am J Respir Crit Care Med 202(9):1262–1270PubMedPubMedCentralCrossRef
48.
Goldstein SL, Akcan-Arikan A, Alobaidi R, Askenazi DJ, Bagshaw SM, Barhight M, Barreto E, Bayrakci B, Bignall ONR, Bjornstad E et al (2022) Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement. JAMA Netw Open 5(9):e2229442PubMedPubMedCentralCrossRef
49.
Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST, Siskind LJ, Hutchens MP, Davidson AJ, Burmeister DM et al (2022) Experimental models of acute kidney injury for translational research. Nat Rev Nephrol 18(5):277–293PubMedCrossRef
50.
51.
Stanski NL, Stenson EK, Cvijanovich NZ, Weiss SL, Fitzgerald JC, Bigham MT, Jain PN, Schwarz A, Lutfi R, Nowak J et al (2020) PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock. Am J Respir Crit Care Med 201(7):848–855PubMedPubMedCentralCrossRef
52.
53.
Horiuchi Y, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Mueller GA et al (2022) Decongestion, kidney injury and prognosis in patients with acute heart failure. Int J Cardiol 354:29–37PubMedCrossRef
54.
Zarbock A, Kullmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, Rajani R, McCorkell S, Arndt C, Wulf H et al (2021) Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg 133(2):292–302PubMedCrossRef
55.
Bhatraju PK, Robinson-Cohen C, Mikacenic C, Harju-Baker S, Dmyterko V, Slivinski NSJ, Liles WC, Himmelfarb J, Heckbert SR, Wurfel MM (2017) Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype. Crit Care 21(1):217PubMedPubMedCentralCrossRef
56.
Lazzareschi D, Mehta RL, Dember LM, Bernholz J, Turan A, Sharma A, Kheterpal S, Parikh CR, Ali O, Schulman IH et al (2022) Overcoming barriers in the design and implementation of clinical trials for Acute Kidney Injury: a report from the 2020 Kidney Disease Clinical Trialists meeting. Nephrol Dial Transplant 38(4):834–844PubMedCentralCrossRef
57.
Engelman DT, Crisafi C, Germain M, Greco B, Nathanson BH, Engelman RM, Schwann TA (2020) Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg 160(5):1235–1246PubMedCrossRef
58.
Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR (2019) News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 71(4):811–822PubMedCrossRef
59.
Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A et al (2021) Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol 12(5):e00359PubMedPubMedCentralCrossRef
60.
Huelin P, Sola E, Elia C, Sole C, Risso A, Moreira R, Carol M, Fabrellas N, Bassegoda O, Juanola A et al (2019) Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study. Hepatology 70(1):319–333PubMedCrossRef
61.
Ro X, C H, DF B (2016) Urinary NGAL biomarker predicts non response to therapy with albumin and terlipressin in patients with hepatorenal syndrome. Hepatology 64(Suppl 1):1035A
62.
Gambino C, Piano S, Stenico M, Tonon M, Brocca A, Calvino V, Incicco S, Zeni N, Gagliardi R, Cosma C et al (2023) Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury. Hepatology 77(5):1630–1638PubMedCrossRef
63.
Fudim M, Loungani R, Doerfler SM, Coles A, Greene SJ, Cooper LB, Fiuzat M, O’Connor CM, Rogers JG, Mentz RJ (2018) Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. Am Heart J 204:163–173PubMedCrossRef
64.
Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, Felker GM, Hernandez AF, O’Connor CM, Sabbisetti VS et al (2018) Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury. Circulation 137(19):2016–2028PubMedPubMedCentralCrossRef
65.
Brisco MA, Zile MR, Hanberg JS, Wilson FP, Parikh CR, Coca SG, Tang WH, Testani JM (2016) Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. J Card Fail 22(10):753–760PubMedPubMedCentralCrossRef
66.
Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, Tang WHW, Skouri H, Verbrugge FH, Orso F et al (2020) Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22(4):584–603PubMedCrossRef
67.
Shrivastava A, Haase T, Zeller T, Schulte C (2020) Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs. Front Cardiovasc Med 7:601364PubMedPubMedCentralCrossRef
68.
Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, Hastbacka J, Khanna AK, Albertson TE, Tumlin J et al (2020) Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock A Clinical Trial. Am J Respir Crit Care Med 202(9):1253–1261PubMedPubMedCentralCrossRef
69.
Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A et al (2018) Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. Crit Care Med 46(6):949–957PubMedPubMedCentralCrossRef
70.
Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887PubMedCrossRef
71.
Moledina DG, Eadon MT, Calderon F, Yamamoto Y, Shaw M, Perazella MA, Simonov M, Luciano R, Schwantes-An TH, Moeckel G et al (2022) Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrol Dial Transplant 37(11):2214–2222PubMedCrossRef
72.
Moledina DG, Wilson FP, Kukova L, Obeid W, Luciano R, Kuperman M, Moeckel GW, Kashgarian M, Perazella MA, Cantley LG et al (2021) Urine interleukin-9 and tumor necrosis factor-alpha for prognosis of human acute interstitial nephritis. Nephrol Dial Transplant 36(10):1851–1858PubMedCrossRef
73.
Moledina DG, Wilson FP, Pober JS, Perazella MA, Singh N, Luciano RL, Obeid W, Lin H, Kuperman M, Moeckel GW et al (2019) Urine TNF-alpha and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight 4:10CrossRef
74.
Stark JE, Opoka AM, Mallela J, Devarajan P, Ma Q, Levinsky NC, Stringer KF, Wong HR, Alder MN (2020) Juvenile OLFM4-null mice are protected from sepsis. Am J Physiol Renal Physiol 318(3):F809–F816PubMedPubMedCentralCrossRef
75.
Hasson DC, Krallman K, VanDenHeuvel K, Menon S, Piraino G, Devarajan P, Goldstein SL, Alder MN (2022) Olfactomedin 4 as a novel loop of Henle-specific acute kidney injury biomarker. Physiol Rep 10(18):e15453PubMedPubMedCentralCrossRef
76.
77.
Stanski NL, Wong HR, Basu RK, Cvijanovich NZ, Fitzgerald JC, Weiss SL, Bigham MT, Jain PN, Schwarz A, Lutfi R et al (2021) Recalibration of the Renal Angina Index for Pediatric Septic Shock. Kidney Int Rep 6(7):1858–1867PubMedPubMedCentralCrossRef
78.
79.
Bagshaw SM, Al-Khafaji A, Artigas A, Davison D, Haase M, Lissauer M, Zacharowski K, Chawla LS, Kwan T, Kampf JP et al (2021) External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury. Crit Care 25(1):185PubMedPubMedCentralCrossRef
80.
Rewa OG, Bagshaw SM, Wang X, Wald R, Smith O, Shapiro J, McMahon B, Liu KD, Trevino SA, Chawla LS et al (2019) The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study. J Crit Care 52:109–114PubMedPubMedCentralCrossRef
81.
Advani A (2020) Acute Kidney Injury: A Bona Fide Complication of Diabetes. Diabetes 69(11):2229–2237PubMedCrossRef
82.
Demirjian S, Bashour CA, Shaw A, Schold JD, Simon J, Anthony D, Soltesz E, Gadegbeku CA (2022) Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery. JAMA 327(10):956–964PubMedPubMedCentralCrossRef
83.
Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, Jones MC (2013) Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clin Med (Lond) 13(3):233–238PubMedCrossRef
84.
Hoste E, Bihorac A, Al-Khafaji A, Ortega LM, Ostermann M, Haase M, Zacharowski K, Wunderink R, Heung M, Lissauer M et al (2020) Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med 46(5):943–953PubMedPubMedCentralCrossRef
85.
Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG (2013) Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 17(5):R207PubMedPubMedCentralCrossRef
86.
Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL et al (2015) Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. J Am Soc Nephrol 26(8):2023–2031PubMedPubMedCentralCrossRef
Metadata
Title
Precision management of acute kidney injury in the intensive care unit: current state of the art
Authors
Natalja L. Stanski
Camila E. Rodrigues
Michael Strader
Patrick T. Murray
Zoltan H. Endre
Sean M. Bagshaw
Publication date
08-08-2023
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 9/2023
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-023-07171-z

Other articles of this Issue 9/2023

Intensive Care Medicine 9/2023 Go to the issue

Correspondence

Driving pressure: pitfalls of methods that do not use esophageal pressure measurement. Author’s reply

Imaging in Intensive Care Medicine

An acute chest pain revealing an inflammatory pericarditis

Correspondence

Avoidance of futile treatment—confluence of human dignity and ecological ethics

Editorial

Tackling sepsis-associated acute kidney injury using routinely collected data

Original

Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study

What's New in Intensive Care

Data-driven approaches to reveal the pathobiological heterogeneity in patients with traumatic brain injury